Telisto Pharmaceuticals Private Limited, a active private limited company, was established on 16 December 2020 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52100TG2020PTC146905. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Employing 17 professional, Its leadership includes Ravi Bellamkonda (Director), Naga Malleswara Rao Rayapati (Director), Pavani Koritala (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No-10-114/17 Satyanarayana Colony, Nagaram, Hyderabad, Telangana, 500083.
U52100TG2020PTC146905
146905
16 December 2020
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Telisto Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Bellamkonda | Director | 03 Feb 2022 | Current |
| Naga Malleswara Rao Rayapati | Director | 16 Dec 2020 | Current |
| Pavani Koritala | Director | 16 Dec 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Telisto Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60909.64% increase. The company also saw a slight improvement in profitability, with a 6.33% increase in profit. The company's net worth observed a substantial decline by a decrease of 98.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Telisto Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Telisto Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Telisto Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Telisto Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Telisto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Telisto Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on Ravi Bellamkonda was appointed as a Director was appointed as a Director on 03 Feb 2022 & has been associated with this company since 3 years 10 months . was documented.
Naga Malleswara Rao Rayapati was appointed as a Director was appointed as a Director on 16 Dec 2020 & has been associated with this company since 5 years 4 days . was recorded as a recent event.
Pavani Koritala was appointed as a Director was appointed as a Director on 16 Dec 2020 & has been associated with this company since 5 years 4 days . was recorded as a recent event.
Telisto Pharmaceuticals Private Limited was registered on 16 Dec 2020 with Roc Hyderabad & aged 5 years 4 days as per MCA records. was recorded as a recent event.
The CIN of Telisto Pharmaceuticals Private Limited is U52100TG2020PTC146905.
Telisto Pharmaceuticals Private Limited is headquartered at H.No-10-114/17 Satyanarayana Colony, Nagaram, Hyderabad, Telangana, 500083.
Telisto Pharmaceuticals Private Limited was incorporated on 16 December 2020.
The current directors of Telisto Pharmaceuticals Private Limited are
The primary industry of Telisto Pharmaceuticals Private Limited is Trade.
Telisto Pharmaceuticals Private Limited is unlisted.
The authorized capital of Telisto Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX